Reuters logo
BRIEF-Champions Oncology announces strategic collaboration with AstraZeneca to develop unique cohorts of PDX models
August 21, 2017 / 12:36 PM / 4 months ago

BRIEF-Champions Oncology announces strategic collaboration with AstraZeneca to develop unique cohorts of PDX models

Aug 21 (Reuters) - Champions Biotechnology Inc

* Champions Oncology announces strategic collaboration with AstraZeneca to develop unique cohorts of patient-derived xenograft (PDX) models

* Champions Biotechnology Inc- ‍cohorts of PDX models will be used in AstraZeneca’s Oncology research and development programs in breast and lung cancer​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below